The rating scale preference measure as an evaluative measure in systemic lupus erythematosus

Lupus

Volumn 9, Issue 9, 2000, Pages 696-701

  Ward, M M ^a   Marx, A S ^a   Barry, N N ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Patient assessment; Preference measures; Rating scale; Sensitivity to change; Systemic lupus erythematosus

Indexed keywords

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE;

EID: 0034536184     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300672399292     Document Type: Article

References (32)

1. Measuring health-related quality of life
2. Measurement of health state utilities for economic appraisal. A review
3. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial
4. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis
5. Stability and responsiveness of utility measures
6. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-item short form health survey, EuroQol, and disease specific measures
7. Generic and disease-specific measures in assessing health status and quality of life
8. On the generalizability of statistical expressions of health related quality of life instrument responsiveness: A data synthesis
9. Can health utility measures be used in lupus research? A comparative validation and reliability study of 4 utility indices
10. Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus
11. Feasibility of utility assessment by rating scale and standard gamble in patients with ankylosing spondylitis or fibromyalgia
12. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus
13. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score
14. Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus
15. Further validation of the BILAG disease activity index in patients with systemic lupus erythematosus
16. Derivation of the SLEDAI. A disease activity index for lupus patients
17. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. III. Development of a computerized clinical chart and its application to the comparison of different indices of disease activity
18. Small changes in outpatient lupus activity are better detected by clinical instruments than by laboratory tests
19. Comparisons of five health status instruments for orthopedic evaluation
20. Pooled time series regression analysis in longitudinal studies
21. Functional health status levels of primary care patients
22. Patient perception of involvement in medical care: Relationship to illness attitudes and outcomes
23. Converging and diverging beliefs about arthritis: Caucasian patients, Spanish speaking patients, and physicians
24. Concordance between clinician and patient assessment of physical and mental health status
25. Agreement between patient self-report and clinician rating: Concurrence between the BSI and the GAF among psychiatric inpatients
26. Ongoing assessment of health status in patients with diabetes mellitus
27. Incorporating utility-based quality-of-life assessment measures in clinical trials. Two examples
28. 'Arthritis specific' global health analog scales assess 'generic' health related quality-of-life in patients with rheumatoid arthritis
29. Validity of Euroqol-a generic health status instrument-in patients with rheumatoid arthritis
30. Patient utilities in fibromyalgia and the association with other outcome measures
31. Patient utilities in ankylosing spondylitis and the association with other outcome measures